| Period Ending | Mar 30, 2012 | Mar 30, 2011 | Mar 30, 2010 |
|---|
|
Total Revenue
|
74,163,000
|
73,550,000
|
67,461,000
| | Cost of Revenue | 50,403,000 | 49,393,000 | 44,657,000 | | |
Gross Profit
|
23,760,000
|
24,156,000
|
22,804,000
| |
|
Operating Expenses |
|
Research Development |
-
|
-
|
-
|
|
Selling General and Administrative | 7,345,000 | 13,438,000 | 12,431,000 |
|
Non Recurring | 6,471,000 | 9,858,000 | 3,186,000 |
|
Others |
-
|
-
|
-
|
|
|
|
Total Operating Expenses |
-
|
-
|
-
| | | |
Operating Income or Loss
|
17,874,000
|
8,970,000
|
14,380,000
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | 470,000 | 6,942,000 | 1,071,000 |
|
Earnings Before Interest And Taxes | 18,344,000 | 15,913,000 | 15,452,000 |
|
Interest Expense | 3,087,000 | 688,000 | 2,294,000 |
|
Income Before Tax | 15,257,000 | 15,225,000 | 13,158,000 |
|
Income Tax Expense | 4,068,000 | 2,610,000 | 85,000 |
|
Minority Interest |
-
|
-
|
-
|
|
|
|
Net Income From Continuing Ops | 19,119,000 | 20,725,000 | 20,266,000 | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
| | | |
Net Income
|
11,189,000
|
12,615,000
|
13,073,000
| | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | |
Net Income Applicable To Common Shares
|
11,189,000
|
12,615,000
|
13,073,000
|
|